Source: Entourage Health Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Entourage Health (ENTG) has partners with HelloMD, a leading online cannabis telehealth company, expanding patient access to healthcare practitioners across Canada
  • Entourage has expanded partnerships with unions, employers, insurers and benefit providers which has seen a surge in patient registrations
  • Starseed debuted a first-of-its-kind digital Patient Treatment Plan for registered patients looking for tailored products along with practical dosing guidelines
  • Entourage’s network of practitioners now specialize in developing personalized patient treatment plans
  • Starseed’s direct-to-patient medical marketplace currently offers over 45 products
  • Entourage Health Corp is a licensed producer and distributor of cannabis products for both the medical and adult-use markets
  • Entourage Health Corp. (ENTG) opened trading at C$0.05

Entourage Health (ENTG) has partners with HelloMD, a leading online cannabis telehealth company, expanding patient access to healthcare practitioners across Canada.

With its Starseed patient base growing over 50 per cent since merging under the Entourage family in late 2019, the company has expanded partnerships with unions, employers, insurers and benefit providers which has seen a surge in patient registrations.

Starseed debuted a first-of-its-kind digital Patient Treatment Plan as a set of core offerings available to registered patients looking for tailored products along with practical dosing guidelines based on recommendations from a health care practitioner. Starseed is the first known provider to offer standardized dosing regimens which could be used as alternate approaches to therapy for chronic pain, sleep and emotional distress, opioid displacement, and mental health support.

Joseph Mele, Chief Commercial Officer, Entourage, commented on the news.

“Expanding our medical platform with enriched patient care, services and new products is reshaping how Canadians access medical cannabis and exemplifies Starseed’s commitment to improving patient outcomes. With the launch of our individualized Patient Treatment Plans, clients and providers can build programs based on specific medical cannabis products and dosing schedule being used to meet their needs.”

Entourage’s network of practitioners now specialize in developing personalized patient treatment plans, a standardized and simplified dosing tool, designed to improve medical cannabis access and overall patient experience.

Starseed recently collaborated with patients to develop the Starseed 2.0 system, a more accurate method for determining cannabinoid profiles – 1 star for high CBD, 2 stars for balanced, and 3 stars for high THC.

“As a team of health care professionals providing medical cannabis guidance, we are committed to offering medical pathways and patient-centric services through technology, innovation, and education to ensure safe and effective use,” said Sara Ryan, Director of Medical Education, Starseed Medicinal.

“Currently, opioids are being overused despite their well-known harm, while patients are often conflicted about safe treatment options. Medical cannabis could be considered an alternative, providing patients with a novel therapeutic option. Empowering patients and health care practitioners with education and resource tools for alternate treatments will help us close this knowledge gap as more people add medical cannabis to their daily self-care regimes.”

Starseed’s comprehensive education and support services could connect visitors with healthcare professionals and/or provide best-in-class education resources keeping patients informed and up-to-date. Available information varies from cannabis news and research treatment options, to support channels.

Starseed’s direct-to-patient medical marketplace currently offers over 45 products, including cannabis-infused soft chews, transdermal patches, compounds (balms), oils, capsules, vapes, and dried flower products.

Entourage Health owns and operates a greenhouse, a 26,000 sq. ft. processing facility, specializing in cannabis extraction; and a micropropagation, tissue culture and genetics centre-of-excellence, all in Ontario.

Entourage Health Corp. (ENTG) opened trading at C$0.05.


More From The Market Herald

" MCI Onehealth (TSX:DRDR) and Euclid Telehealth work to improve patient vision

MCI Onehealth (DRDR) and Euclid Telehealth are collaborating to increase access to care that can potentially prevent vision loss among Ontario patients.

" Spectral Medical (TSX:EDT) reports Q2 2022 results

Spectral Medical (EDT) released its financial results for the second quarter ended June 30, 2022.

" Hemostemix (TSXV:HEM) closes second tranche of non-brokered private placement

Hemostemix (HEM) has closed the second tranche of a non-brokered private placement of units for gross proceeds of $1,364,710.10.

" Nova Leap Health (TSXV:NLH) posts 2nd highest Q2 results in its history

Nova Leap Health (NLH) released its financial results for the quarter ended June 30, 2022.